EPS for Aphria Inc. (APH) Expected At $-0.01

September 16, 2018 - By Elizabeth Bryant

Analysts expect Aphria Inc. (TSE:APH) to report $-0.01 EPS on October, 12.They anticipate $0.11 EPS change or 110.00 % from last quarter’s $0.1 EPS. After having $-0.04 EPS previously, Aphria Inc.’s analysts see -75.00 % EPS growth. The stock increased 13.01% or $2.25 during the last trading session, reaching $19.55. About 19.00 million shares traded or 157.30% up from the average. Aphria Inc. (TSE:APH) has 0.00% since September 16, 2017 and is . It has underperformed by 15.62% the S&P500.

Aphria Inc. produces, supplies, and sells medical cannabis in Canada. The company has market cap of $4.54 billion. The firm offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It has a 108.61 P/E ratio. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.

More notable recent Aphria Inc. (TSE:APH) news were published by: Profitconfidential.com which released: “Recreational Marijuana Market” on September 13, 2018, also Midasletter.com with their article: “VIDEO: 420Investor Founder Alan Brochstein on Influx of US Investment Dollars into Cannabis Space” published on September 07, 2018, Midasletter.com published: “VIDEO: Liberty Health Sciences Inc (CNSX:LHS) Success in Florida Market” on September 12, 2018. More interesting news about Aphria Inc. (TSE:APH) were released by: Benzinga.com and their article: “Everything You Need To Know From The Cannabis Capital Conference” published on August 24, 2018 as well as Profitconfidential.com‘s news article titled: “Marijuana News Today: Pot Stock Market Still Roaring, Virginia Opens the Door to CBD Oil” with publication date: August 21, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.